ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $215,000 | -61.5% | 11,414 | -76.6% | 0.01% | -80.0% |
| Q4 2017 | $558,000 | -17.0% | 48,767 | -11.0% | 0.04% | -26.2% |
| Q3 2017 | $672,000 | -32.3% | 54,819 | -36.8% | 0.06% | -35.1% |
| Q2 2017 | $993,000 | +214.2% | 86,692 | +470.8% | 0.09% | +213.3% |
| Q1 2017 | $316,000 | -40.4% | 15,188 | -6.0% | 0.03% | -46.4% |
| Q3 2016 | $530,000 | +129.4% | 16,162 | +130.9% | 0.06% | +55.6% |
| Q4 2015 | $231,000 | +492.3% | 7,000 | +483.3% | 0.04% | +500.0% |
| Q3 2015 | $39,000 | -39.1% | 1,200 | 0.0% | 0.01% | -33.3% |
| Q2 2015 | $64,000 | +220.0% | 1,200 | +71.4% | 0.01% | +200.0% |
| Q1 2015 | $20,000 | -37.5% | 700 | -36.4% | 0.00% | -40.0% |
| Q4 2014 | $32,000 | – | 1,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |